Reduced injection risk and sexual risk behaviours after drug misuse treatment: Results from the National Treatment Outcome Research Study

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 14, Issue 1, 2002, Pages 77-93

  Gossop, Michael ^a   Marsden, J ^a   Stewart, D ^a   Treacy, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG MISUSE; ETHNOLOGY; FEMALE; GENDER; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SAFE SEX; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; NEEDLE-EXCHANGE PROGRAMS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 0036146925     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120220097955     Document Type: Article

References (61)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. HIV risk-taking behavior among injecting drug users currently, previously, and never enrolled in methadone treatment
3. Characterizing 'nonresponsive' methadone patients
4. Accuracy of perceptions of hepatitis B and C status: Cross sectional investigation of opiate addicts in treatment
5. HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences
6. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance
7. Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior
8. Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993
9. Heroin-related deaths in South Western Sydney, Australia, 1992-96
10. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients
11. A scale for estimating the health status of opioid users
12. HIV infection among intravenous drug users: Epidemiology and emerging public health perspectives
13. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners
14. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium
15. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users
16. Chasing the dragon: Characteristics of heroin chasers
17. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment
18. Severity of heroin dependence and HIV risk. I. Sexual behaviour
19. Frequency of non-fatal heroin overdose: Survey of heroin users recruited in non-clinical settings
20. The National Treatment Outcome Research Study in the United Kingdom: 6-month follow-up outcomes
21. Substance use, health and social problems of service users at 54 drug treatment agencies: Intake data from the National Treatment Outcome Research Study
22. Treatment retention and 1 year outcomes for residential programmes in England
23. Patterns of improvement after methadone treatment: One year follow-up results from the National Treatment Outcome Research Study (NTORS)
24. Outcomes after methadone maintenance and methadone reduction treatments: Two year follow-up results from the National Treatment Outcome Research Study
25. A prospective study of mortality among drug misusers during a four year period after seeking treatment
26. Multiple risks for HIV and hepatitis B infection among heroin users
27. Sexual behaviour and its relationship to drug taking among prostitutes in south London
28. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City
29. Overview of 1-year follow-up outcomes in the drug abuse treatment outcome study (DATOS)
30. Predictors of increased condom use following HIV intervention with heterosexually active drug users
31. Injection drug users, drug treatment and HIV risk behaviour
32. Methadone maintenance and needle/syringe sharing
33. Depressive symptoms, drug network, and the synergistic effect on needle-sharing behavior among street injection drug users
34. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis
35. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome
36. Psychiatric symptoms amongst clients seeking treatment for drug dependence: Intake data from the National Treatment Outcome Research Study
37. The effects of planned duration of residential drug abuse treatment on recovery and HIV risk behavior
38. Drug abuse treatment as AIDS prevention
39. Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An 18-month prospective follow-up
40. Effectiveness of treatment for substance abuse and dependence for dual diagnosis patients: A model of treatment factors associated with one-year outcomes
41. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990
42. Heroin, risk and sexual safety: Some problems for interventions encouraging community change
43. The prevalence of psychiatric disorders in patients with alcohol and other drug problems
44. Heterogeneity of psychiatric diagnosis in treated opiate addicts
45. Sterile needles and the epidemic of acquired immunodeficiency syndrome: Issues for drug abuse treatment and public health
46. Needle use behaviour
47. Drug abuse treatment as an HIV prevention strategy: A review
48. AIDS and drug injecting in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic
49. The better-travelled treatment tourist: Service overlap among heroin and cocaine users
50. Which drugs cause overdose among opiate misusers? Study of personal and witnessed overdoses
51. Drink, illicit drugs and unsafe sex in women
52. Racial differences in HIV infection and risk behaviours among drug users in a low seroprevalence area
53. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users